A Novel Path
How will the first and only FDA-approved prescription cannabidiol appeal to a healthcare industry which has had a long-standing aversion to marijuana-based drugs? Our answer is a modern and patient-focused campaign that reflects the novelty of the rare disease treatment while maintaining a clinical feel that caters to those cautious of the marijuana stigma. ̌
Working closely with UX, rebranded and launched the Epidiolex HCP website. Keeping patients at the focus, we reimagined all visuals including charts, a dosing calculator, and chat bot.
Sample of pages from brand guidelines booklet
Designed object recognition tables for the Epidiolex booth at the 2019 American Epilepsy Society (AES) annual meeting. This interactive experience tackles common misconceptions about prescribing Epidiolex.
Sample from a section about patient characteristics.
